Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 2,358 shares at $26.78 ($63K) on 2026-05-22, disclosed to the SEC on 2026-05-26.
Seasonal sale ($63k) by CHIEF DEVELOPMENT OFFICER — this insider has traded KALV in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KALV | SELL | 2026-05-19 | $30K | — | Filing → |
| KALV | SELL | 2026-02-24 | $68K | — | Filing → |
| KALV | SELL | 2026-02-19 | $17K | — | Filing → |